Back to top

healthcare: Archive

Neena Mishra

AI, Cancer Vaccines, and Next-Gen Medicine

Could cancer vaccines and AI drive the next wave of healthcare innovation?

MRNANegative Net Change HLTHNegative Net Change CANCNegative Net Change

Kaibalya Pravo Dey

UnitedHealth Stock Rises 39% in 6 Months: Should Investors Still Buy?

UNH's 39% six-month rally reflects improving medical costs, stronger earnings estimates and a sharper focus on profitable businesses.

UNHPositive Net Change HUMPositive Net Change ELVPositive Net Change

Kaibalya Pravo Dey

Centene Stock Roars Back 117% in a Year: Is CNC Still a Buy?

CNC's 117% rally now has support from improving margins, firmer pricing and higher earnings expectations, while valuation remains below key peers.

CNCPositive Net Change UNHPositive Net Change ELVPositive Net Change

Tanuka De

Oscar Health Skyrockets 109% YTD: Time to Bet on the Stock Now?

Oscar Health has surged 109% YTD as membership, revenue and expansion plans strengthen, though its price-to-book multiple tops the industry average.

OSCRPositive Net Change MOHPositive Net Change CNCPositive Net Change

Rajshree Sipani

UnitedHealth vs. Elevance: Which Managed-Care Stock Is a Better Buy?

UNH outpaces ELV with stronger earnings prospects, improving Medicare profitability, greater upside and a more favorable risk-reward profile.

UNHPositive Net Change ELVPositive Net Change

Kaibalya Pravo Dey

UnitedHealth Stock Looks Reasonable at 18.39X P/E: Should You Buy Now?

UNH's improving medical costs, higher EPS estimates and capital returns support its recovery, but regulatory risks remain.

UNHPositive Net Change HUMPositive Net Change ELVPositive Net Change

Shrabana Mukherjee

Leading Women-Run Companies Shaping the Future of Business

CNC, DAR, GD, FCEL and CC stocks show how women-led companies are redefining growth with discipline, agility and results.

GDPositive Net Change DARPositive Net Change CNCPositive Net Change FCELNegative Net Change CCPositive Net Change

Zacks Equity Research

CVS Q2 Earnings Call Pairs Aetna Recovery With 2027 PBM Risks

CVS Health lifts its 2026 outlook on Aetna's recovery and retail strength while flagging 2027 pressure from 340B changes and Caremark membership declines.

CVSPositive Net Change

Rajshree Sipani

UnitedHealth vs. Centene: Which Managed Care Stock Is the Better Buy?

UNH's diversified platform, AI expansion and Optum momentum strengthen its long-term outlook, making it the stronger managed care pick over CNC.

UNHPositive Net Change CNCPositive Net Change

Kaibalya Pravo Dey

UnitedHealth's Cost-Control Story is Gaining Momentum: Time to Buy?

UNH's improving cost control, lower medical costs and higher 2026 outlook are boosting confidence as its profitability recovery gains traction.

UNHPositive Net Change MOHPositive Net Change CNCPositive Net Change